Prediction of age-related macular degeneration in the general population: the Three Continent AMD Consortium.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Ophthalmology (Rochester, Minn.)

• Publication date

  2013-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.ophtha.2013.07.053PMID 24120328PMCID PMC3986722
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Harmonizing the Classification of Age-related Macular Degeneration in the Three-Continent AMD Consortium

  2014cited by this paper
• Variants in the VEGFA gene and treatment outcome after anti-VEGF treatment for neovascular age-related macular degeneration.

  2013cited by this paper
• Seven New Loci Associated with Age-Related Macular Degeneration

  2013cited by this paper
• Modelling the Genetic Risk in Age-Related Macular Degeneration

  2012cited by this paper
• Prospective assessment of genetic effects on progression to different stages of age-related macular degeneration using multistate Markov models.

  2012cited by this paper
• Risk alleles in CFH and ARMS2 are independently associated with systemic complement activation in age-related macular degeneration.

  2012cited by this paper
• Cumulative effect of risk alleles in CFH, ARMS2, and VEGFA on the response to ranibizumab treatment in age-related macular degeneration.

  2012cited by this paper
• Role of vascular endothelial growth factor polymorphisms in the treatment success in patients with wet age-related macular degeneration.

  2012cited by this paper
• Assessing susceptibility to age-related macular degeneration with genetic markers and environmental factors.

  2011cited by this paper
• Risk assessment model for development of advanced age-related macular degeneration.

  2011cited by this paper
• Clinical validation of a genetic model to estimate the risk of developing choroidal neovascular age-related macular degeneration

  2011cited by this paper
• Using Genetic Variation and Environmental Risk Factor Data to Identify Individuals at High Risk for Age-Related Macular Degeneration

  2011cited by this paper
• Healthy lifestyles related to subsequent prevalence of age-related macular degeneration.

  2011cited by this paper
• Reducing the genetic risk of age-related macular degeneration with dietary antioxidants, zinc, and ω-3 fatty acids: the Rotterdam study.

  2011cited by this paper
• Strengthening the reporting of genetic risk prediction studies (GRIPS): explanation and elaboration

  2011cited by this paper
• Development of a risk score for geographic atrophy in complications of the age-related macular degeneration prevention trial.

  2011cited by this paper
• Risk models for progression to advanced age-related macular degeneration using demographic, environmental, genetic, and ocular factors.

  2011cited by this paper
• [The Rotterdam study].

  2011cited by this paper
• The Rotterdam Study: 2012 objectives and design update

  2011cited by this paper
• A genetic approach to stratification of risk for age-related macular degeneration.

  2010cited by this paper
• Determination of a gene and environment risk model for age-related macular degeneration

  2010cited by this paper
• Complement Component 3: an assessment of association with AMD and analysis of gene-gene and gene-environment interactions in a Northern Irish cohort

  2010cited by this paper
• Genome-wide association identifies SKIV2L and MYRIP as protective factors for age-related macular degeneration

  2010cited by this paper
• Interpretation of Genetic Association Studies: Markers with Replicated Highly Significant Odds Ratios May Be Poor Classifiers

  2009cited by this paper
• Dietary compound score and risk of age-related macular degeneration in the age-related eye disease study.

  2009cited by this paper
• Plasma complement components and activation fragments: associations with age-related macular degeneration genotypes and phenotypes.

  2009cited by this paper
• Prediction model for prevalence and incidence of advanced age-related macular degeneration based on genetic, demographic, and environmental variables.

  2009cited by this paper
• C2 and CFB Genes in Age-Related Maculopathy and Joint Action with CFH and LOC387715 Genes

  2008cited by this paper
• Dietary antioxidants and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study.

  2008cited by this paper
• Association of complement factor H and LOC387715 genotypes with response of exudative age-related macular degeneration to intravitreal bevacizumab.

  2007cited by this paper
• Neovascular Age-Related Macular Degeneration Risk Based on CFH, LOC387715/HTRA1, and Smoking

  2007cited by this paper
• The Rotterdam Study: 2010 objectives and design update

  2007cited by this paper
• Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration

  2006cited by this paper
• Prevalence of age-related maculopathy in older Europeans: the European Eye Study (EUREYE).

  2006cited by this paper
• Complement factor H polymorphism, complement activators, and risk of age-related macular degeneration.

  2006cited by this paper
• Dietary intake of antioxidants and risk of age-related macular degeneration.

  2005cited by this paper
• Causes and prevalence of visual impairment among adults in the United States.

  2004cited by this paper
• Missense variations in the fibulin 5 gene and age-related macular degeneration.

  2004cited by this paper
• REVIEW: Epidemiology of age-related maculopathy: a review

  2003cited by this paper
• Epidemiology of age-related maculopathy: a review.

  2003cited by this paper
• Population-based cohort studies.

  1998cited by this paper
• Age-specific prevalence and causes of blindness and visual impairment in an older population: the Rotterdam Study.

  1998cited by this paper
• Familial aggregation of age-related maculopathy.

  1997cited by this paper
• Smoking is also associated with age-related macular degeneration in persons aged 85 years and older: The Rotterdam Study.

  1997cited by this paper
• Age-related macular degeneration and smoking. The Rotterdam Study.

  1996cited by this paper
• An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group.

  1995cited by this paper
• An international classification and grading system for age-related maculopathy and age-related macular degeneration

  1995cited by this paper
• Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study.

  1995cited by this paper
• The Beaver Dam Eye Study: visual acuity.

  1991cited by this paper
• The Wisconsin age-related maculopathy grading system.

  1991cited by this paper
• Determinants of disease and disability in the elderly: The Rotterdam elderly study

  1991cited by this paper
• Modern Epidemiology 3rd edition

  1986cited by this paper
• [Modern epidemiology].

  1971cited by this paper

• Artificial intelligence-driven diagnosis for age-related macular degeneration bridging pathology and engineering: a survey

  2025influential citation
• Predictive performance of an updated polygenic risk score for age-related macular degeneration.

  2024cites this paper
• Exploring causal relationships between immune cells and age-related macular degeneration through univariable, bidirectional, and multivariable Mendelian analysis

  2024cites this paper
• Identification of Genetic Variants for Risk Prediction and Early Diagnosis of Age-Related Macular Degeneration in the Taiwanese Population

  2024cites this paper
• A link between Androgenetic Alopecia and Aging

  2024influential citation
• Metabolic Shift and Hyperosmolarity Underlie Age-Related Macular Degeneration

  2024cites this paper
• Recent Updates on the Diagnosis and Management of Age-Related Macular Degeneration

  2024cites this paper
• Age-Related Macular Degeneration in an Ageing Society – Current Epidemiological Research

  2023cites this paper
• Emerging therapeutic strategies for unmet need in neovascular age-related macular degeneration

  2023cites this paper
• Geographic Atrophy in Age-Related Macular Degeneration

  2023cites this paper
• An injectable thermosensitive hydrogel encapsulating tetramethylpyrazine nanocrystals alleviates angiogenesis and apoptosis in a choroidal neovascularization mouse model

  2023cites this paper
• Systematic review of prognostic factors associated with progression to late age-related macular degeneration: Pinnacle study report 2.

  2023cites this paper
• Family History of AMD and Genetics Predict Progression to Advanced AMD Adjusting for Macular Status, Demographic and Lifestyle Factors.

  2023cites this paper
• Evaluating a Causal Relationship between Complement Factor I Protein Level and Advanced Age-Related Macular Degeneration Using Mendelian Randomization

  2022cites this paper
• Genetic Aspects of Age-Related Macular Degeneration and Their Therapeutic Potential

  2022cites this paper
• Prevalence and risk factors for age-related macular degeneration in a population-based cohort study of older adults in Northern Ireland using multimodal imaging: NICOLA Study

  2022cites this paper
• WARE: Wet AMD Risk-Evaluation Tool as a Clinical Decision-Support System Integrating Genetic and Non-Genetic Factors

  2022cites this paper
• Genetic disorders causing non-syndromic retinopathy

  2022cites this paper
• Optimized Prediction Models from Fundus Imaging and Genetics for Late Age-Related Macular Degeneration

  2021cites this paper
• Exploring Consensus on Preventive Measures and Identification of Patients at Risk of Age-Related Macular Degeneration Using the Delphi Process

  2021cites this paper
• Enlargement of Geographic Atrophy From First Diagnosis to End of Life.

  2021cites this paper
• Risk Stratification and Clinical Utility of Polygenic Risk Scores in Ophthalmology

  2021cites this paper
• Predicting progression to advanced age-related macular degeneration from clinical, genetic and lifestyle factors using machine learning.

  2020cites this paper
• Development of a Genotype Assay for Age-Related Macular Degeneration: The EYE-RISK Consortium.

  2020cites this paper
• Intravenous anti-VEGF agents with RGD peptide-targeted core cross-linked star (CCS) polymers modified with indocyanine green for imaging and treatment of laser-induced choroidal neovascularization.

  2020cites this paper
• Neovascular Age-Related Macular Degeneration: Therapeutic Management and New-Upcoming Approaches

  2020cites this paper
• Multimodal Evaluation of Visual Function in Geographic Atrophy versus Normal Eyes

  2020cites this paper
• Artificial Intelligence to Stratify Severity of Age-Related Macular Degeneration (AMD) and Predict Risk of Progression to Late AMD

  2020cites this paper
• OPTH_A_246245 1533..1545

  2020cites this paper
• Risk factors for progression of age‐related macular degeneration

  2020cites this paper
• A Multi-Omics Approach Identifies Key Regulatory Pathways Induced by Long-Term Zinc Supplementation in Human Primary Retinal Pigment Epithelium

  2020cites this paper
• Novel Porcine Retina Cultivation Techniques Provide Improved Photoreceptor Preservation

  2020cites this paper
• The Role of Inflammation in Age-Related Macular Degeneration

  2020cites this paper
• Genetic risk score has added value over initial clinical grading stage in predicting disease progression in age-related macular degeneration

  2019cites this paper
• The use of real-world evidence for evaluating anti-vascular endothelial growth factor treatment of neovascular age-related macular degeneration.

  2019cites this paper
• Assessing the performance of genome-wide association studies for predicting disease risk

  2019cites this paper
• Dyslipidemia in retinal metabolic disorders

  2019cites this paper
• Visual benefit versus visual gain: what is the effect of baseline covariants in the treatment arm relative to the control arm? A pooled analysis of ANCHOR and MARINA

  2019cites this paper
• The Significance of Screening Questionnaire in the Evaluation of Age-Related Macular Risk Degeneration Development

  2019cites this paper
• Значение скрининговых опросников для выявления риска развития возрастной макулярной дегенерации

  2019cites this paper
• Essays on the impact of vision impairment in Portugal

  2019influential citation
• The role of complement system and other inflammatory factors in the development of age-related macular degeneration

  2018cites this paper
• Exploring functional clinical attributes for macular dystrophy detection

  2018cites this paper
• Vitamin D and Age-Related Macular Degeneration

  2018cites this paper
• Complement System and Age-Related Macular Degeneration: Implications of Gene-Environment Interaction for Preventive and Personalized Medicine

  2018cites this paper
• Age-related macular degeneration

  2018cites this paper
• Exploring Factors Underlying Ethnic Difference in Age-related Macular Degeneration Prevalence

  2018cites this paper
• How Do Patients Respond to Genetic Testing for Age-related Macular Degeneration?

  2018cites this paper
• Investigating the modulation of genetic effects on late AMD by age and sex: Lessons learned and two additional loci

  2018cites this paper
• Dietary, environmental, and genetic risk factors of Extensive Macular Atrophy with Pseudodrusen, a severe bilateral macular atrophy of middle-aged patients

  2018cites this paper
• Innovative Approaches in Delivery of Eye Care: Age-Related Macular Degeneration

  2018cites this paper
• Wogonin induces retinal neuron-like differentiation of bone marrow stem cells by inhibiting Notch-1 signaling

  2017cites this paper
• Development and Validation of a Risk Score for Age-Related Macular Degeneration: The STARS Questionnaire.

  2017cites this paper
• A decade of age-related macular degeneration risk models: What have we learned from them and where are we going?

  2017cites this paper
• Five-year progression of unilateral age-related macular degeneration to bilateral involvement: the Three Continent AMD Consortium report

  2017cites this paper
• Predictive models of long-term anatomic outcome in age-related macular degeneration treated with as-needed Ranibizumab

  2017cites this paper
• Vitamin D and Age-Related Macular Degeneration

  2017cites this paper
• Molecular response of chorioretinal endothelial cells to complement injury: implications for macular degeneration

  2016cites this paper
• Risk Prediction Model for Progression of Age-Related Macular Degeneration

  2016cites this paper
• Omics in Ophthalmology: Advances in Genomics and Precision Medicine for Leber Congenital Amaurosis and Age-Related Macular Degeneration.

  2016cites this paper
• The Application of Genetic Risk Scores in Age-Related Macular Degeneration: A Review

  2016cites this paper
• Toward personalized medicine in age-related macular degeneration

  2016cites this paper
• Assessing the Causality between Blood Pressure and Retinal Vascular Caliber through Mendelian Randomisation

  2016cites this paper
• Genetics and age-related macular degeneration: a practical review for the clinician

  2016cites this paper
• Statistical and experimental analysis of genetic and non-genetic markers associated with risk and progression of age-related macular degeneration (AMD)

  2016cites this paper
• Ophthalmic epidemiology in Europe: the “European Eye Epidemiology” (E3) consortium

  2016cites this paper
• Worsening anatomic outcomes following aflibercept for neovascular age-related macular degeneration in eyes previously well controlled with ranibizumab

  2016cites this paper
• Epidemiology of Reticular Pseudodrusen in Age-Related Macular Degeneration: The Rotterdam Study.

  2016cites this paper
• Whole exome sequencing of extreme age-related macular degeneration phenotypes

  2016cites this paper
• Features of Age-Related Macular Degeneration in the General Adults and Their Dependency on Age, Sex, and Smoking: Results from the German KORA Study

  2016cites this paper
• Descemet-membrane endothelial keratoplasty in patients with retinal comorbidity-a prospective cohort study.

  2016cites this paper
• Genetics of Unilateral and Bilateral Age-Related Macular Degeneration Severity Stages

  2016cites this paper
• Management of neovascular age-related macular degeneration: current state-of-the-art care for optimizing visual outcomes and therapies in development

  2015cites this paper
• Familial macular disease. Clinical and genetic studies on age-related macular degeneration and inherited macular dystrophies

  2015cites this paper
• Investigation of the genetic epidemiology of age-related macular degeneration, primary open-angle glaucoma, and diabetic retinopathy in diverse populations

  2015cites this paper
• What Does Genetics Tell Us About Age-Related Macular Degeneration?

  2015cites this paper
• Rare genetic variants in patients with age-related macular degeneration

  2015cites this paper
• Genetic testing for age-related macular degeneration: progress and perspectives

  2015cites this paper
• The genetics of age-related macular degeneration (AMD)--Novel targets for designing treatment options?

  2015cites this paper
• Aggregate Effects of Intraocular Pressure and Cup-to-Disc Ratio Genetic Variants on Glaucoma in a Multiethnic Asian Population.

  2015cites this paper
• CORRELATION BETWEEN NEOVASCULAR LESION TYPE AND CLINICAL CHARACTERISTICS OF NONNEOVASCULAR FELLOW EYES IN PATIENTS WITH UNILATERAL, NEOVASCULAR AGE-RELATED MACULAR DEGENERATION

  2015cites this paper
• Relationship between the complement system, risk factors and prediction models in age-related macular degeneration.

  2015cites this paper
• A Validated Phenotyping Algorithm for Genetic Association Studies in Age-related Macular Degeneration

  2015cites this paper
• Diffusion of anti-VEGF injections in the Portuguese National Health System

  2015cites this paper
• Genetic risk of neurodegenerative diseases is associated with mild cognitive impairment and conversion to dementia

  2015cites this paper
• Molecular Immunology

  2015cites this paper
• Small Drusen and Age-Related Macular Degeneration: The Beaver Dam Eye Study

  2015cites this paper
• Age-related macular degeneration and the role of the complement system.

  2015cites this paper
• The Contribution of Genetic Architecture to the 10-Year Incidence of Age-Related Macular Degeneration in the Fellow Eye.

  2015cites this paper
• Tapping Stem Cells to Target AMD: Challenges and Prospects

  2015cites this paper
• Age-Related Macular Degeneration: Linking Clinical Presentation to Pathology

  2014cites this paper
• Genome-wide association studies: getting to pathogenesis, the role of inflammation/complement in age-related macular degeneration.

  2014cites this paper
• Quantitative SD-OCT imaging biomarkers as indicators of age-related macular degeneration progression.

  2014cites this paper
• Age-related macular degeneration: genetics and biology coming together.

  2014cites this paper
• Genetic evidence for role of carotenoids in age-related macular degeneration in the Carotenoids in Age-Related Eye Disease Study (CAREDS).

  2014cites this paper
• Long-term longitudinal study of patients treated with ranibizumab for neovascular age-related macular degeneration

  2014cites this paper
• Genome-Wide Association Studies: Getting to Pathogenesis, the Role of Inflammation / Complement in AMD

  2014cites this paper
• Is age‐related macular degeneration a manifestation of systemic disease? New prospects for early intervention and treatment

  2014cites this paper
• Macular dystrophies mimicking age-related macular degeneration.

  2014cites this paper
• Direct-to-consumer personal genome testing for age-related macular degeneration.

  2014cites this paper